RUARK, E, SNAPE, K, HUMBURG, P, LOVEDAY, C, BAJRAMI, I, BROUGH, R, RODRIGUES, D.N, RENWICK, A, SEAL, S, RAMSAY, E, DEL VECCHIO DUARTE, S, RIVAS, A. M, WARREN-PERRY, M, ZACHARIOU, A, CAMPION-FLORA, A, HANKS, S, MURRAY, A, POUR, N.A, DOUGLAS, J, GREGORY, J, RIMMER, A, WALKER, N.M, YANG, T-P, ADLARD, J.W, BARWELL, J, BERG, J, BRADY, A.F, BREWER, C, BRICE, G, CHAPMAN, C, COOK, J, DAVIDSON, R, DONALDSON, A, DOUGLAS, F, ECCLES, D, EVANS, D.G, GREENHALGH, L, HENDERSON, A, IZATT, L, KUMAR, A, LALLOO, F, MIEDZYBRODZKA, Z, MORRISON, P.J, PATERSON, J, PORTEOUS, M, ROGERS, M.T, SHANLEY, S, WALKER, L, GORE, M, HOULSTON, R, BROWN, M.A, CAUFIELD, M.J, DELOUKAS, P, MCCARTHY, M.I, TODD, J.A, the BREAST AND OVARIAN CANCER SUSCEPTIBILITY COLLABORATION,WELLCOME TRUST CASE CONTROL CONSORTIUM, TURNBULL, C, REIS-FILHO, J.S, ASHWORTH, A, ANTONIOU, A.C, LORD, C.J, DONNELLY, P and RAHMAN, N.
(2013)
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer.
Nature, 493(7432), 406–410.